DK3269386T3 - Aluminiumforbindelser til anvendelse inden for behandling og i vacciner - Google Patents

Aluminiumforbindelser til anvendelse inden for behandling og i vacciner Download PDF

Info

Publication number
DK3269386T3
DK3269386T3 DK17185526.5T DK17185526T DK3269386T3 DK 3269386 T3 DK3269386 T3 DK 3269386T3 DK 17185526 T DK17185526 T DK 17185526T DK 3269386 T3 DK3269386 T3 DK 3269386T3
Authority
DK
Denmark
Prior art keywords
vaccines
treatment
aluminum compounds
aluminum
compounds
Prior art date
Application number
DK17185526.5T
Other languages
English (en)
Inventor
Michael Weber
Jürgen Wruss
Robert Schlegl
Michael Möhlen
Original Assignee
Valneva Austria Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47294919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3269386(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/054387 external-priority patent/WO2013135274A1/en
Application filed by Valneva Austria Gmbh filed Critical Valneva Austria Gmbh
Application granted granted Critical
Publication of DK3269386T3 publication Critical patent/DK3269386T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/104Pseudomonadales, e.g. Pseudomonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24111Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK17185526.5T 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse inden for behandling og i vacciner DK3269386T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11192230 2011-12-06
PCT/EP2012/054387 WO2013135274A1 (en) 2012-03-13 2012-03-13 Aluminium compounds for use in therapeutics and vaccines
EP16183076.5A EP3106176B1 (en) 2011-12-06 2012-12-06 Aluminium compounds for use in therapeutics and vaccines

Publications (1)

Publication Number Publication Date
DK3269386T3 true DK3269386T3 (da) 2022-10-24

Family

ID=47294919

Family Applications (6)

Application Number Title Priority Date Filing Date
DK12795830.4T DK2788023T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner
DK16183076.5T DK3106176T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutika og vacciner
DK20184308.3T DK3785730T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner
DK17185526.5T DK3269386T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse inden for behandling og i vacciner
DKBA201300194U DK201300194U1 (da) 2011-12-06 2013-12-09 Aluminiumhydroxidkoncentrat, fortrinsvis til anvendelse i fremstillingen af en vaccine
DKBA201300193U DK201300193U1 (da) 2011-12-06 2013-12-09 Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DK12795830.4T DK2788023T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner
DK16183076.5T DK3106176T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutika og vacciner
DK20184308.3T DK3785730T3 (da) 2011-12-06 2012-12-06 Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner

Family Applications After (2)

Application Number Title Priority Date Filing Date
DKBA201300194U DK201300194U1 (da) 2011-12-06 2013-12-09 Aluminiumhydroxidkoncentrat, fortrinsvis til anvendelse i fremstillingen af en vaccine
DKBA201300193U DK201300193U1 (da) 2011-12-06 2013-12-09 Aluminiumforbindelser til anvendelse i terapeutiske produkter og vacciner.

Country Status (15)

Country Link
EP (5) EP3106176B1 (da)
CY (1) CY1119927T1 (da)
DE (1) DE202012012768U1 (da)
DK (6) DK2788023T3 (da)
ES (2) ES2930458T3 (da)
FI (1) FI3785730T3 (da)
HR (1) HRP20171871T1 (da)
HU (1) HUE037325T2 (da)
LT (1) LT3106176T (da)
NO (1) NO3106176T3 (da)
PL (2) PL3269386T3 (da)
PT (2) PT3269386T (da)
RS (1) RS56709B1 (da)
SI (1) SI3106176T1 (da)
WO (1) WO2013083726A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2788023T3 (da) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines
MX2017002803A (es) 2014-09-03 2017-06-09 Intervet Int Bv Coronavirus bovino atenuado y vacunas relacionadas.
WO2017109225A1 (en) 2015-12-23 2017-06-29 Valneva Austria Gmbh Zika virus vaccine
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CN118662649A (zh) 2016-12-30 2024-09-20 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
ES2957939T3 (es) 2017-04-13 2024-01-30 Valneva Austria Gmbh Polipéptidos de OspA multivalentes y métodos y usos relacionados con los mismos
JP7301811B2 (ja) 2017-09-21 2023-07-03 ヴァルネヴァ エスイー 免疫原性チクングニアウイルスchikv-delta 5nsp3を含む医薬組成物を製造する方法
CN111511395B (zh) 2017-11-03 2024-10-15 武田疫苗股份有限公司 用于将寨卡病毒灭活和用于确定灭活完全性的方法
JP2021505549A (ja) 2017-11-30 2021-02-18 タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. ジカワクチン及び免疫原性組成物、ならびにその使用方法
CA3106286A1 (en) 2018-07-13 2020-01-16 Valneva Se Method for rescuing and producing a virus in avian cells
CA3138064A1 (en) 2019-05-20 2020-11-26 Valneva Se A subunit vaccine for treatment or prevention of a respiratory tract infection
WO2021178306A1 (en) * 2020-03-01 2021-09-10 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
WO2021176434A1 (en) 2020-03-01 2021-09-10 Valneva Austria Gmbh Cpg-adjuvanted sars-cov-2 virus vaccine
EP3895729A1 (en) 2020-03-01 2021-10-20 Valneva Austria GmbH Cpg-adjuvanted sars-cov-2 virus vaccine
WO2021178318A1 (en) * 2020-03-01 2021-09-10 Dynavax Technologies Corporation Coronavirus vaccines comprising a tlr9 agonist
MX2022010642A (es) * 2020-03-01 2022-11-08 Dynavax Tech Corp Vacunas contra coronavirus que comprenden un agonista de tlr9.
WO2021204825A2 (en) 2020-04-06 2021-10-14 Valneva Austria Gmbh INACTIVATED SARS-CoV-2 VIRUS VACCINE
CA3174599A1 (en) 2020-04-09 2021-10-14 Robert Schlegl Improvements in vaccine formulations for medical use
AU2022255923A1 (en) 2021-04-09 2023-08-31 Valneva Se Human metapneumo virus vaccine
WO2023148256A1 (en) 2022-02-02 2023-08-10 Valneva Austria Gmbh Inactivated sars-cov-2 virus vaccine
WO2023232901A1 (en) 2022-06-01 2023-12-07 Valneva Austria Gmbh Clostridium difficile vaccine
WO2024153686A1 (en) 2023-01-18 2024-07-25 Valneva Austria Gmbh Process for virus production in a bioreactor

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4761372A (en) 1981-01-12 1988-08-02 New York University Mutant enterotoxin of E. coli
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4882317A (en) 1984-05-10 1989-11-21 Merck & Co., Inc. Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5308835A (en) 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
CA2059692C (en) 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
AUPO264096A0 (en) 1996-09-30 1996-10-24 Mclaughlin Geosurveys Pty Ltd. Value improvement of clays
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
CN1142271C (zh) 1997-08-28 2004-03-17 第一制糖株式会社 适应非洲绿猴肾细胞的减毒的日本脑炎病毒和其疫苗
EP1109576B1 (en) 1998-08-19 2009-10-21 Baxter Healthcare SA Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
WO2002064162A2 (en) 2001-02-13 2002-08-22 Government Of The United States, As Represented By The Secretary Of The Army Vaccine for transcutaneous immunization
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
US20110189217A1 (en) * 2008-06-26 2011-08-04 Barry Michael A Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
CN101734698B (zh) 2009-09-08 2013-01-09 东北大学 一种由含铝物料制备氧化铝的方法
DK2788023T3 (da) 2011-12-06 2016-12-19 Valneva Austria Gmbh Aluminiumforbindelser til anvendelse i terapeutiske midler og vacciner

Also Published As

Publication number Publication date
EP3106176A1 (en) 2016-12-21
HUE037325T2 (hu) 2018-08-28
EP2788023B1 (en) 2016-11-02
EP3106176B1 (en) 2017-10-11
FI3785730T3 (fi) 2024-05-06
NO3106176T3 (da) 2018-03-10
DK3106176T3 (da) 2018-01-08
EP3785730B1 (en) 2024-04-24
DK201300193U1 (da) 2014-01-17
DK2788023T3 (da) 2016-12-19
EP4400115A3 (en) 2024-10-23
DE202012012768U1 (de) 2014-01-21
EP3269386B1 (en) 2022-09-14
EP4400115A2 (en) 2024-07-17
DK201300194U1 (da) 2014-01-17
CY1119927T1 (el) 2018-12-12
SI3106176T1 (en) 2018-04-30
PT3269386T (pt) 2022-12-05
ES2647882T3 (es) 2017-12-27
EP2788023A1 (en) 2014-10-15
EP3269386A1 (en) 2018-01-17
PL3106176T3 (pl) 2018-03-30
DK3785730T3 (da) 2024-05-06
PL3269386T3 (pl) 2022-12-05
HRP20171871T1 (hr) 2018-01-12
EP3785730A1 (en) 2021-03-03
LT3106176T (lt) 2018-01-10
PT3106176T (pt) 2017-12-20
ES2930458T3 (es) 2022-12-13
WO2013083726A1 (en) 2013-06-13
RS56709B1 (sr) 2018-03-30

Similar Documents

Publication Publication Date Title
DK3269386T3 (da) Aluminiumforbindelser til anvendelse inden for behandling og i vacciner
DK2925782T3 (da) Anti-cd47-antistoffer og fremgangsmåder til anvendelse deraf
DK2428450T3 (da) Doseringsmetode og doseringsindretning
DK2950535T3 (da) Fremgangsmåde og indretning til at afkode intra-forudsigelsestilstand
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK2857401T3 (da) Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme
DK2914627T3 (da) Anti-cd40-antistoffer og fremgangsmåder til anvendelse
DK2734128T3 (da) Kirurgisk hentningsindretning med halvstift udtrækkelig og sammenklappelig kurv
DK2903600T3 (da) Virusholdig formulering og anvendelse deraf
DK3358011T3 (da) Peptid til inducering af regenerering af væv og anvendelse deraf
DK3197164T3 (da) Afkodningsanordning og afkodningsfremgangsmåde
DK2900657T3 (da) Cykliske etherpyrazol-4-yl-heterocyclyl-carboxamidforbindelser og fremgangsmåder til anvendelse
DK2931143T3 (da) Implantat og føring til kæbe-ansigts-kirurgi
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
DK2838900T3 (da) Forbindelser og fremgangsmåder til antiviral behandling
DK3045187T3 (da) Injektor og fremgangsmåde til samling
DK2672967T3 (da) Forbindelser og fremgangsmåder til kinasemodulering og indikationer derfor
DK2920313T3 (da) Rekombinante adenovira og anvendelse deraf
DK3550836T3 (da) Fremgangsmåde og anordning til afkodning
DK2895607T3 (da) Dobbeltstrengede oligonukleotidmolekyler til ddit4 og fremgangsmåder til anvendelse deraf
BR302012003126S1 (pt) Configuração aplicada em empunhadura para intrumento médico
DK2815769T3 (da) Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet
DK2795210T3 (da) Køleelement og køleindretning
DK2693816T3 (da) Fremgangsmåde og enhed til brug i rammegenkendelse
BR112014020761A2 (pt) Aparelho médico e método